EMEA-001230-PIP01-11-M05
Key facts
| Invented name |
Latuda
|
| Active substance |
Lurasidone hydrochloride
|
| Therapeutic area |
Psychiatry
|
| Decision number |
P/0359/2019
|
| PIP number |
EMEA-001230-PIP01-11-M05
|
| Pharmaceutical form(s) |
Film-coated tablet
|
| Condition(s) / indication(s) |
Treatment of schizophrenia
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO - A.C.R.A.F. S.p.A.
Tel. +3906780531 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-001230-PIP01-11-M05
|
| Compliance opinion date |
11/12/2019
|
| Compliance outcome |
positive
|